The UK Medicines and Healthcare Products Regulatory Authority has accepted Biosplice's application for treatment of knee osteoarthritis and has officially initiated an evaluation process.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.